Rapport Therapeutics, Inc. RAPP
- RAP-219 — Focal Onset Seizures Phase 3
- RAP-219 — Bipolar Mania Phase 2
- RAP-219 Preclinical
- RAP-219 — Primary Generalized Tonic-Clonic Seizures
Home › Targets › AMPA receptor
Companies with an active program directed at AMPA receptor.